Physician profile
James Steward
NPI 1215371950
$831.95
in general payments reported to CMS, 2019-2025
20 companies · $181 in 2025
The $181 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $17.53 · 2021: $18.11 · 2022: $129 · 2023: $190 · 2024: $154 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $524.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $124.96 | 2023-2024 | Orgovyx |
| Astellas Pharma US INC | $110.07 | 2019-2023 | Myrbetriq |
| Olympus America INC. | $87.25 | 2023-2025 | Itind System |
| Ferring Pharmaceuticals INC. | $64.49 | 2024-2025 | Adstiladrin |
| Boston Scientific Corporation | $48.50 | 2022-2023 | Rezum Generator |
| Medtronic USA, INC. | $44.41 | 2019 | |
| Merck Sharp & Dohme LLC | $41.92 | 2020-2023 | Keytruda, Lynparza |
| Medtronic, INC. | $40.58 | 2022-2023 | Interstim |
| Zimmer Biomet Holdings, INC. | $34.00 | 2019 | |
| Procept Biorobotics Corporation | $33.27 | 2022 | |
| Avyxa Pharma, LLC | $29.71 | 2025 | |
| Novartis Pharmaceuticals Corporation | $28.12 | 2025 | |
| Angiodynamics, INC. | $23.20 | 2025 | Nanoknife |
| Teleflex LLC | $22.60 | 2023 | Urolift |
| Photocure INC | $18.86 | 2024 | Cysview |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $18.16 | 2024 | |
| Convatec INC. | $18.11 | 2021 | |
| Koelis INC. | $16.18 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.28 | 2025 | |
| Pfizer INC. | $12.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Steward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.